Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
Status:
COMPLETED
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.